Home › Funds › Siren, L.L.C. › DBVT
Siren, L.L.C. position in DBVT
Dbv Technologies SA · Health Care
Siren, L.L.C. reported holding 2,356,539 shares of DBVT (Dbv Technologies SA) in its Q3 2026 13F filing — a position valued at US$27.7M, representing 0.66% of its reported portfolio and ranking #37 among its reported holdings. Siren, L.L.C. has disclosed DBVT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Siren, L.L.C.'s DBVT position evolved
Siren, L.L.C. first disclosed a stake in DBVT in Q4 2025 at 1,857,362 shares (US$35.6M). The position peaked in Q1 2026 at 1,857,362 shares, worth US$38.8M. Across 4 filings, Siren, L.L.C. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,356,539 shares valued at US$27.7M — an increase of 499,177 shares quarter over quarter.. Notable position changes include a 27% increase in Q3 2026 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.86M | $35.61M | New |
| Q1 2026 | 1.86M | $38.80M | Hold |
| Q2 2026 | 1.86M | $30.46M | Hold |
| Q3 2026 | 2.36M | $27.71M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DBVT and 13F data
DBVT (Dbv Technologies SA) is a Health Care company. 57 other funds we track also report a position in DBVT — the largest reported positions include MPM BioImpact LLC (US$60.1M), Vivo Capital, LLC (US$30.3M), PERCEPTIVE ADVISORS LLC (US$27.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DBVT
- MPM BioImpact LLC 3.67M sh · $60.13M · Q2 2026
- Vivo Capital, LLC 1.84M sh · $30.25M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.65M sh · $27.11M · Q2 2026
- Logos Global Management LP 915.00K sh · $15.01M · Q2 2026
- Patient Square Capital LP 909.47K sh · $14.92M · Q2 2026
- Octagon Capital Advisors LP 574.20K sh · $9.42M · Q2 2026
- Redmile Group, LLC 410.44K sh · $6.73M · Q2 2026
- Elmind Capital, LP 265.00K sh · $4.35M · Q2 2026
- Ishara Investments LP 184.50K sh · $3.03M · Q2 2026
- Yiheng Capital Management, L.P. 170.14K sh · $2.79M · Q2 2026
- GREAT POINT PARTNERS LLC 156.91K sh · $2.57M · Q2 2026
More on Siren, L.L.C.
FAQ
How long has Siren, L.L.C. held DBVT?
Siren, L.L.C. has disclosed DBVT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Siren, L.L.C.'s current position in DBVT?
As of Q3 2026, Siren, L.L.C. holds 2.36M shares of DBVT (Dbv Technologies SA), valued at $27.71M, representing 0.66% of its reported portfolio and ranking #37.
Has Siren, L.L.C. been buying or selling DBVT?
In the latest 13F filing (Q3 2026), Siren, L.L.C. increased its position in DBVT. The position peaked in Q1 2026 at 1.86M shares.
Which other funds hold DBVT?
Other major institutional holders of DBVT include MPM BioImpact LLC, Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.